Exercise, Arterial Cross-Talk Modulation and Inflammation in an Ageing Population

NACompletedINTERVENTIONAL
Enrollment

158

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

December 31, 2017

Study Completion Date

February 28, 2018

Conditions
Cardiovascular DiseaseObesityAtherosclerosisHeart; Disease, Activity
Interventions
OTHER

Training or control condition

Participants get a 12 week high intensity and walking-based interval training which is adapted to their individual physical fitness level or a general recommendation on physical activity according to European Guidelines.

Trial Locations (1)

4052

Bereich Sport- und Bewegungsmedizin, Abteilung Präventive Sportmedizin & Systemphysiologie, Basel

All Listed Sponsors
collaborator

University Hospital, Basel, Switzerland

OTHER

collaborator

Basel Institute of Clinical Epidemiology (BICE)

OTHER

lead

University of Basel

OTHER

NCT02796976 - Exercise, Arterial Cross-Talk Modulation and Inflammation in an Ageing Population | Biotech Hunter | Biotech Hunter